IRCT201604201556N88已完成未知
Carnosine as adjuvant therapy in the treatment of moderate to severe OCD: a double blind randomized trial with placebo control
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: 1-Age between 18-60years old; 2-Diagnosis of OCD based on DSM V; 3- Minimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale.
排除标准
- •1- Substance dependence; 2- IQ <70; 3- Any other mental disorder on axis I; 4-Any serious cardiac, renal or hepatic disease; 5- receiving psychotropic medications during the last 6 weeks; 6- pregnancy or breast feeding; 7- Rising liver transaminases to three times the upper limit of normal or higher.
研究者
相似试验
已完成
3 期
carnosine in SchizophreniaCTRI/2019/02/017646Brio Bliss life science pvtltd100
招募中
2 期
carnosine in treatment of major depressive disorderIRCT20170123032145N2Iran University of Medical Sciences50
已完成
3 期
carnosine in patients with schizophreniaschizophrenia.schizophreniaIRCT201504211556N75Tehran University of Medical Sciences50
招募中
2 期
Carnitine for the treatment of autismIRCT20090117001556N136Tehran University of Medical Sciences50
已完成
不适用
Carnosine in the treatment of AutismAutistic Disorder.Childhood autismIRCT201512081556N83Tehran University of Medical Sciences50